Marshall Wace, LLP Danaher Corp Transaction History

Marshall Wace, LLP

  • $63.3 Billion
  • Q1 2024

A detailed history of Marshall Wace, LLP transactions in Danaher Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 2,921,162 shares of DHR stock, worth $730 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
2,921,162
Previous 1,777,980 64.3%
Holding current value
$730 Million
Previous $411 Million 77.35%
% of portfolio
1.15%
Previous 0.72%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$224.58 - $256.19 $257 Million - $293 Million
1,143,182 Added 64.3%
2,921,162 $729 Million
Q4 2023

Feb 14, 2024
SELL
$185.1 - $233.13 $107 Million - $135 Million
-578,582 Reduced 24.55%
1,777,980 $411 Million
Q3 2023

Nov 14, 2023
BUY
$233.08 - $265.59 $293 Million - $334 Million
1,258,472 Added 114.61%
2,356,562 $585 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $60 Million - $68.3 Million
-266,542 Reduced 19.53%
1,098,090 $264 Million
Q1 2023

May 15, 2023
BUY
$239.75 - $277.0 $136 Million - $157 Million
567,933 Added 71.29%
1,364,632 $344 Million
Q4 2022

Feb 14, 2023
BUY
$241.42 - $282.29 $172 Million - $201 Million
710,584 Added 825.16%
796,699 $211 Million
Q3 2022

Nov 14, 2022
BUY
$247.06 - $1507.4 $21.3 Million - $130 Million
86,115 New
86,115 $22.2 Million
Q2 2022

Aug 15, 2022
SELL
$237.11 - $299.66 $16.5 Million - $20.9 Million
-69,629 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$257.27 - $315.76 $67.7 Million - $83.1 Million
-263,223 Reduced 79.08%
69,629 $20.4 Million
Q4 2021

Feb 14, 2022
BUY
$292.08 - $329.01 $57.1 Million - $64.3 Million
195,381 Added 142.13%
332,852 $110 Million
Q3 2021

Nov 15, 2021
SELL
$272.21 - $332.43 $96.2 Million - $117 Million
-353,378 Reduced 71.99%
137,471 $41.9 Million
Q2 2021

Aug 13, 2021
BUY
$225.08 - $271.69 $79.7 Million - $96.2 Million
354,200 Added 259.2%
490,849 $132 Million
Q1 2021

May 17, 2021
SELL
$212.38 - $245.9 $53.4 Million - $61.9 Million
-251,609 Reduced 64.8%
136,649 $30.8 Million
Q4 2020

Feb 16, 2021
BUY
$212.5 - $245.46 $60 Million - $69.2 Million
282,120 Added 265.8%
388,258 $86.2 Million
Q3 2020

Nov 16, 2020
SELL
$177.16 - $215.33 $37.5 Million - $45.5 Million
-211,482 Reduced 66.58%
106,138 $22.9 Million
Q2 2020

Aug 13, 2020
BUY
$128.7 - $176.83 $40.9 Million - $56.2 Million
317,620 New
317,620 $56.2 Million
Q1 2020

May 15, 2020
SELL
$121.39 - $169.05 $757,959 - $1.06 Million
-6,244 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$133.47 - $153.48 $73.1 Million - $84 Million
-547,413 Reduced 98.87%
6,244 $958,000
Q3 2019

Nov 14, 2019
BUY
$135.4 - $146.47 $71 Million - $76.8 Million
524,602 Added 1805.55%
553,657 $80 Million
Q2 2019

Aug 14, 2019
SELL
$124.88 - $143.73 $11.4 Million - $13.1 Million
-91,120 Reduced 75.82%
29,055 $4.15 Million
Q1 2019

May 14, 2019
BUY
$97.62 - $132.29 $11.2 Million - $15.2 Million
114,533 Added 2030.01%
120,175 $15.9 Million
Q4 2018

Feb 14, 2019
SELL
$94.85 - $109.54 $5.2 Million - $6 Million
-54,808 Reduced 90.67%
5,642 $582,000
Q3 2018

Nov 14, 2018
BUY
$98.13 - $108.9 $4.99 Million - $5.54 Million
50,874 Added 531.27%
60,450 $6.57 Million
Q2 2018

Aug 14, 2018
BUY
$96.1 - $103.24 $920,253 - $988,626
9,576 New
9,576 $945,000
Q1 2018

May 15, 2018
SELL
$92.16 - $103.8 $1.6 Million - $1.81 Million
-17,412 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$85.26 - $94.62 $1.48 Million - $1.65 Million
17,412
17,412 $1.62 Million

Others Institutions Holding DHR

# of Institutions
2,371
Shares Held
559M
Call Options Held
3.54M
Put Options Held
3.99M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $182B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email